Qiagen NV (Qiagen NV) Interest Expense : $-53 Mil (TTM As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Qiagen NV's interest expense for the three months ended in Dec. 2023 was $ -12 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-53 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Qiagen NV's Operating Income for the three months ended in Dec. 2023 was $ 121 Mil. Qiagen NV's Interest Expense for the three months ended in Dec. 2023 was $ -12 Mil. Qiagen NV's Interest Coverage for the quarter that ended in Dec. 2023 was 9.77. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Qiagen NV Interest Expense Historical Data

The historical data trend for Qiagen NV's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Interest Expense Chart

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-74.19

-71.32

-54.48

-58.36

-53.41

Qiagen NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-14.88	-14.45	-13.50	-13.02	-12.44

Qiagen NV Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-53 Mil.

Qiagen NV (NYSE:QGEN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Qiagen NV's Interest Expense for the three months ended in Dec. 2023 was $-12 Mil. Its Operating Income for the three months ended in Dec. 2023 was $121 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $922 Mil.

Qiagen NV's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	121.49	/	-12.441
	=	9.77

The higher the ratio, the stronger the company's financial strength is.

Qiagen NV (Qiagen NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » Interest Expense

Comparable Companies

EXAS NTRA CRL MEDP RVTY RDNT DGX SHC NEOG GH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Executives